T 1089/11 (Serum-free medium/BAVARIAN NORDIC) of 12.12.2017
- European Case Law Identifier
- ECLI:EP:BA:2017:T108911.20171212
- Date of decision
- 12 December 2017
- Case number
- T 1089/11
- Petition for review of
- -
- Application number
- 03766057.8
- IPC class
- C12N 5/0735
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- METHOD FOR THE AMPLIFICATION OF A POXVIRUS UNDER SERUM FREE CONDITIONS
- Applicant name
- Bavarian Nordic A/S
- Opponent name
- Emergent Product Development UK Limited
Sanofi Pasteur
Transgene S.A. - Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(1)European Patent Convention Art 123(2)European Patent Convention Art 123(3)European Patent Convention Art 54(3) 1973European Patent Convention Art 54(4) 1973European Patent Convention Art 56European Patent Convention Art 83European Patent Convention Art 84European Patent Convention Art 87Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- Admission of documents (68) and (69) - (no)
Added matter - (no)
Clarity - (yes)
Sufficiency of disclosure - (yes)
Priority - (yes)
Novelty - (yes)
Inventive step - (yes) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeals are dismissed.